{"id":"W1969329034","doi":"10.1002/hep.22044","title":"Herbal product use by persons enrolled in the hepatitis C Antiviral Long-Term Treatment Against Cirrhosis (HALT-C) Trial","year":2007,"lang":"en","type":"article","venue":"Hepatology","topic":"Drug-Induced Hepatotoxicity and Protection","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":133,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Institute on Minority Health and Health Disparities; National Center for Research Resources; National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Allergy and Infectious Diseases; National Institutes of Health; Valeant Pharmaceuticals International; University of Colorado School of Medicine, Anschutz Medical Campus; University of Connecticut; Vertex Pharmaceuticals; New England Research Institutes; Virginia Commonwealth University; University of Southern California; National Cancer Institute; National Institute on Alcohol Abuse and Alcoholism; Saint Louis University; Massachusetts General Hospital; GlaxoSmithKline; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; University of Washington","keywords":"Medicine; Cirrhosis; Hepatitis C; Term (time); Internal medicine; Gastroenterology; Antiviral treatment; Virology; Chronic hepatitis; Virus","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001381046,0.000283579,0.0008399604,0.0002964603,0.0004987531,0.0006817475,0.0002346273,0.0006776552,0.001979516],"category_scores_gemma":[0.002168743,0.0002858143,0.0009444107,0.0005046786,0.0002218811,0.0006145018,0.0003248221,0.0009123055,0.0002898843],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002339319,"about_ca_system_score_gemma":0.0002469019,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001413751,"about_ca_topic_score_gemma":0.001817185,"domain_scores_codex":[0.9991806,0.000386025,0.00007936314,0.0001025155,0.000125187,0.0001263569],"domain_scores_gemma":[0.9992489,0.0002262644,0.0002024653,0.00006318672,0.00008057164,0.000178533],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1943803,0.003829506,0.7630506,0.0006273202,0.00241661,0.0002897599,0.000406784,0.0004070883,0.003075415,0.0001946981,0.003593501,0.02772851],"study_design_scores_gemma":[0.02082099,0.03004813,0.9407449,0.0001715688,0.001777538,0.0002626346,0.000322879,0.001123509,0.0005815972,0.000210557,0.003884017,0.00005165825],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9941718,0.001897284,0.0001063812,0.0001580396,0.00005322249,0.0002982991,0.001582558,0.000008061662,0.001724334],"genre_scores_gemma":[0.9960091,0.0005927716,0.0001004983,0.0002882286,0.00006171563,0.0002840655,0.001620447,0.00000320809,0.001039955],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001979516,"threshold_uncertainty_score":0.007303715,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1353335158968113,"score_gpt":0.4163967744758667,"score_spread":0.2810632585790555,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}